Obstructive sleep apnea as a cause of neurogenic hypertension

Current Hypertension Reports

Volumn 1, Issue 3, 1999, Pages 268-273

  Narkiewicz, Krzysztof ^a   Somers, Virend K ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC SYSTEM; HEART; HUMAN; HYPERTENSION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SLEEP; SLEEP APNEA SYNDROME; WAKEFULNESS;

HEART; HUMANS; HYPERTENSION; SLEEP; SLEEP APNEA, OBSTRUCTIVE; SYMPATHETIC NERVOUS SYSTEM; WAKEFULNESS;

EID: 0033139463     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-999-0032-7     Document Type: Review

References (40)

1. DiBona GF: Sympathetic neural control of the kidney in hypertension. Hypertension 1990, 19:I28-I35.
2. Abel PW, Hermsmeyer K: Sympathetic cross-innervation of SHR and genetic controls suggests a trophic influence on vascular muscle membranes. Circ Res 1981, 49: 1311-1318.
3. Chapleau MW, Abboud FM: Mechanism of adaptation and resetting of the baroreceptor reflex. In Cardiovascular Reflex Control in Health and Disease Edited by R Hainsworth and AL Mark. London: WB Saunders;1993: 165-193.
4. Goldstein DS: Plasma catecholamine and essential hypertension: an analytical review. Hypertension 1983, 5: 86-99.
5. Esler M, Jennings G, Lambert G: Noradrenaline release and the pathophysiology of primary human hypertension. Am J Hypertens 1989, 2:140S-146S. (Pubitemid 19082354)
6. Somers VK, Mark AL, Abboud FM: Potentiation of sympathetic nerve responses to hypoxia in borderline hypertensive subjects. Hypertension 1988, 11: 608-612.
7. Rea RF, Hamdan M: Baroreflex control of muscle sympathetic nerve activity in borderline hypertension. Circulation 1990, 82: 856-862.
8. Anderson EA, Sinkey CA, Lawton WJ, Mark AL: Elevated sympathetic nerve activity in borderline hypertensive humans: evidence from direct intraneural recordings. Hypertension 1989, 14: 177-183.
9. Matsukawa T, Mano T, Gotoh E, Ishii M: Elevated sympathetic nerve activity in patients with accelerated essential hypertension. J Clin Invest 1993, 92: 25-28.
10. Miyajima E, Yamada Y, Yoshida Y, et al.: Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism. Hypertension 1991, 17: 1057-1062.
11. Converse RL, Jacobsen TN, Toto RD, et al.: Sympathetic overactivity in patients with chronic renal failure. New Engl J Med 1992, 327: 1912-1918.
12. Scherrer U, Vissing SF, Morgan BJ, et al.: Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. New Engl J Med 1990, 323: 693-699.
13. Schobel HP, Fischer T, Heuszer K, et al.: Preeclampsia-a state of sympathetic overactivity. New Engl J Med 1996, 335: 1480-1485.
14. Kales A, Cadieux RJ, Shaw LC, et al.: Sleep apnea in a hypertensive population. Lancet 1984, 2: 1005-1008.
15. Koskenvuo M, Kaprio J, Partinen M, et al.: Snoring as a risk factor for hypertension and angina pectoris. Lancet 1985, 1: 89-95.
16. Brooks D, Horner RL, Kozar LF, et al.: Obstructive sleep apnea as a cause of systemic hypertension: evidence from a canine model. J Clin Invest 1997, 99: 106-109.
17. Young T, Finn L, Hla KM, et al.: Snoring as a part of a doseresponse relationship between sleep-disordered breathing and blood pressure. Sleep 1996, 19:S202-S205. (Pubitemid 27138529)
18. Somers VK, Zavala DC, Mark AL, Abboud FM: Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans. J Appl Physiol 1989, 67: 2095-2100.
19. Somers VK, Zavala DC, Mark AL, Abboud FM:Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol 1989, 67: 2101-2106.
20. Przybylski J, Trzebski A, Czyzewski T, Jodkowski J: Responses to hyperoxia, hypoxia, hypercapnia and almitrine in spontaneously hypertensive rats. Bull Eur Physiopathol Respir 1982, 18: 145-154.
21. Trzebski A, Tafil M, Zoltowski M, Przybylski J: Increased sensitivity of the arterial chemoreceptor drive in young men with mild hypertension. Cardiovasc Res 1982, 16: 163-172.
22. Fletcher EC, Miller J, Schaaf JW, Fletcher JG: Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep 1987, 10: 35-44.
23. Marrone O, Riccobono L, Salvaggio A, et al.: Catecholamines and blood pressure in obstructive sleep apnea syndrome. Chest 1993, 103: 722-727.
24. Hedner J, Ejnell H, Sellgren J, et al.: Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? J Hypertens 1988, 6(suppl):529-S531.
25. Somers VK, Dyken ME, Clary MP, Abboud FM: Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995, 96: 1897-1904.
26. Palatini P, Julius S: Heart rate and cardiovascular risk. J Hypertens 1997, 15: 3-17.
27. Singh JP, Larson MG, Tsuji H, et al.: Reduced heart rate variability: a risk factor for new onset hypertension [abstract]. Circulation 1997, 96:I406.
28. Narkiewicz K, Montano N, Cogliati C, et al.: Altered cardiovascular variability in obstructive sleep apnea. Circulation 1998, 98: 1071-1077.
29. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology: Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 1996, 93: 1043-1065.
30. Frattola A, Parati G, Cuspidi C, et al.: Prognostic value of 24-hour blood pressure variability. J Hypertens 1993, 11: 1133-1137.
31. Palatini P, Penzo M, Racioppa A, et al.: Clinical relevance of nighttime blood pressure and of daytime blood pressure variability. Arch Int Med 1992, 152: 1855-1860.
32. Van Vliet BN, Hu L, Scott T, et al.: Cardiac hypertrophy and telemetered blood pressure 6 wk after baroreceptor denervation in normotensive rats. Am J Physiol 1996, 271:R1759-1769.
33. Narkiewicz K, van de Borne PJH, Montano N, et al.: Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 1998, 97: 943-945.
34. Hornyak MM, Cejnar M, Elam M, et al.: Sympathetic muscle nerve activity during sleep in man. Brain 1991, 114: 1281-1295.
35. Okada H, Iwase S, Mano T, et al.: Changes in muscle sympathetic nerve activity in sleep during sleep in humans. Neurology 1991, 41: 1961-1966.
36. Somers VK, Dyken ME, Mark AL, Abboud FM: Sympathetic nerve activity during sleep in normal humans. N Engl J Med 1993, 328: 303-307.
37. Suzuki M, Otsuka K, Guilleminault C: Long-term nasal continuous positive airway pressure administration can normalize hypertension in obstructive sleep apnea patients. Sleep 1993, 16: 545-549.
38. Wilcox I, Grunstein RR, Hedner JA, et al.: Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea. Sleep 1993, 16: 539-544.
39. Waradekar NV, Sinoway LI, Zwillich CW, Leuenberger UA: Influence of treatment on muscle sympathetic nerve activity in sleep apnea. Am J Respir Crit Care Med 1996, 153: 1333-1338.
40. Phillips BG, Narkiewicz K, Pesek CA, et al.: Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 1999, 17: 61-66.